Clobazam
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00349 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | febrile infection-related epilepsy syndrome | KG + DL |
| 2 | perioral myoclonia with absences | KG + DL |
| 3 | cryptogenic late-onset epileptic spasms | KG + DL |
| 4 | photosensitive occipital lobe epilepsy | KG + DL |
| 5 | atypical childhood epilepsy with centrotemporal spikes | KG + DL |
| 6 | childhood onset epileptic encephalopathy | KG + DL |
| 7 | benign occipital epilepsy | KG + DL |
| 8 | early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation | KG + DL |
| 9 | restless legs syndrome | KG + DL |
| 10 | polymicrogyria with optic nerve hypoplasia | KG + DL |
| 11 | neonatal/infantile epilepsy syndrome | KG + DL |
| 12 | nodular neuronal heterotopia | KG + DL |
| 13 | intellectual disability-hypotonia-spasticity-sleep disorder syndrome | KG + DL |
| 14 | trigeminal nerve neoplasm | KG + DL |
| 15 | polyhydramnios, megalencephaly, and symptomatic epilepsy | KG + DL |
| 16 | PSAT deficiency | KG + DL |
| 17 | glutamate pyruvate transaminase 2 deficiency | KG + DL |
| 18 | Al Kaissi syndrome | KG + DL |
| 19 | SATB2 associated disorder | KG + DL |
| 20 | developmental delay and seizures with or without movement abnormalities | KG + DL |
| 21 | congenital insensitivity to pain with severe intellectual disability | KG + DL |
| 22 | polymicrogyria | KG + DL |
| 23 | microlissencephaly-micromelia syndrome | KG + DL |
| 24 | PSPH deficiency | KG + DL |
| 25 | developmental and speech delay due to SOX5 deficiency | KG + DL |
| 26 | intellectual disability-epilepsy-extrapyramidal syndrome | KG + DL |
| 27 | recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome | KG + DL |
| 28 | hypotrichosis-intellectual disability, Lopes type | KG + DL |
| 29 | global developmental delay-osteopenia-ectodermal defect syndrome | KG + DL |
| 30 | Rahman syndrome | KG + DL |
| 31 | spastic paraplegia-glaucoma-intellectual disability syndrome | KG + DL |
| 32 | serine biosynthesis pathway deficiency, infantile/juvenile form | KG + DL |
| 33 | global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome | KG + DL |
| 34 | acute encephalopathy with biphasic seizures and late reduced diffusion | KG + DL |
| 35 | Gomez-Lopez-Hernandez syndrome | KG + DL |
| 36 | spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome | KG + DL |
| 37 | central nervous system calcification-deafness-tubular acidosis-anemia syndrome | KG + DL |
| 38 | shoulder and girdle defects-familial intellectual disability syndrome | KG + DL |
| 39 | Davis Lafer syndrome | KG + DL |
| 40 | Cartwright Nelson Fryns syndrome | KG + DL |
| 41 | Cantu sanchez-corona fragoso syndrome | KG + DL |
| 42 | Elliott ludman Teebi syndrome | KG + DL |
| 43 | GRIN2B-related developmental delay, intellectual disability and autism spectrum disorder | KG + DL |
| 44 | intellectual disability-microcephaly-phalangeal-facial abnormalities syndrome | KG + DL |
| 45 | intellectual disability-hypotonia-skin hyperpigmentation syndrome | KG + DL |
| 46 | Qazi Markouizos syndrome | KG + DL |
| 47 | infantile choroidocerebral calcification syndrome | KG + DL |
| 48 | hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome | KG + DL |
| 49 | Grubben-de Cock-Borghgraef syndrome | KG + DL |
| 50 | primary microcephaly-mild intellectual disability-young-onset diabetes syndrome | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.